Table 2.
Ligand | Analyte | ka (M−1s−1) x 106 | kd (s−1) x 10−3 | KD (nM) | χ2 |
---|---|---|---|---|---|
ΔNucleolin | ARPC2 GQ | 8.7 | 5.1 | 0.6 | 0.96 |
ARPC2 mut | 0.5 | 41.4 | 83 | 1.61 | |
MMP16 GQ | 0.92 | 1.9 | 2 | 0.79 | |
MMP16 mut | 6 | 3.6 | 0.6 | 0.94 | |
U2AF65 | ARPC2 GQ | 1.1 | 1.2 | 1 | 0.9 |
ARPC2 mut | n. d. | ||||
MMP16 GQ | 1.6 | 8.1 | 5 | 0.73 | |
MMP16 mut | n. d. |